The GWPH chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GWPH chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The GWPH stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View GWPH Detailed Price Forecast - CNN Money||View GWPH Detailed Summary - Google Finance|
|View GWPH Detailed Summary - Yahoo! Finance||View GWPH Stock Research & Analysis - Zacks.com|
|View GWPH Trends & Analysis - Trade-Ideas||View GWPH Major Holders - Barrons|
|View GWPH Call Transcripts - NASDAQ||View GWPH Breaking News & Analysis - Seeking Alpha|
|View GWPH Annual Report - CompanySpotlight.com||View GWPH OTC Short Report - OTCShortReport.com|
|View GWPH Fundamentals - TradeKing||View GWPH SEC Filings - Bar Chart|
|View Historical Prices for GWPH - The WSJ||View Performance/Total Return for GWPH - Morningstar|
|View the Analyst Estimates for GWPH - MarketWatch||View the Earnings History for GWPH - CNBC|
|View the GWPH Earnings - StockMarketWatch||View GWPH Buy or Sell Recommendations - MacroAxis|
|View the GWPH Bullish Patterns - American Bulls||View GWPH Short Pain Metrics - ShortPainBot.com|
|View GWPH Stock Mentions - StockTwits||View GWPH Stock Mentions - PennyStockTweets|
|View GWPH Stock Mentions - Twitter||View GWPH Investment Forum News - Investor Hub|
|View GWPH Stock Mentions - Yahoo! Message Board||View GWPH Stock Mentions - Seeking Alpha|
|View Insider Transactions for GWPH - SECform4.com||View Insider Transactions for GWPH - Insider Cow|
|View GWPH Major Holdings Summary - CNBC||View Insider Disclosure for GWPH - OTC Markets|
|View Insider Transactions for GWPH - Yahoo! Finance||View Institutional Holdings for GWPH - NASDAQ|
|View GWPH Stock Insight & Charts - FinViz.com||View GWPH Investment Charts - StockCharts.com|
|View GWPH Stock Overview & Charts - BarChart||View GWPH User Generated Charts - Trading View|
GW Pharmaceuticals and Greenwich Biosciences Announce FDA Acceptance of sNDA Filing with Priority Review for EPIDIOLEX® (cannabidiol) in the Treatment of Seizures Associated with Tuberous Sclerosis Complex
Posted on Tuesday March 31, 2020
GW Pharmaceuticals plc (GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with its U.S. subsidiary Greenwich Biosciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with Priority Review its recently submitted supplemental New Drug Application (sNDA) for the use of EPIDIOLEX® (cannabidiol) CV to treat seizures associated with Tuberous Sclerosis Complex (TSC). The PDUFA (Prescription Drug User Fee Act) goal date for completion of the FDA review of the EPIDIOLEX sNDA is July 31, 2020.
Why This Biotech Stock And Its CBD Oil Are Immune To Coronavirus
Posted on Tuesday March 24, 2020
GW Pharmaceuticals and its CBD oil are immune to coronavirus, according to an analyst — prodding GWPH stock to pop Monday and Tuesday. The drug, Epidiolex, treats several forms of epilepsy.
Does GW Pharmaceuticals plc's (NASDAQ:GWPH) CEO Pay Compare Well With Peers?
Posted on Friday March 20, 2020
In 1999 Justin Gover was appointed CEO of GW Pharmaceuticals plc (NASDAQ:GWPH). This report will, first, examine the...
GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency (EMA) to expand the use of EPIDYOLEX®, (cannabidiol) oral solution, for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC)
Posted on Friday March 13, 2020
LONDON, March 13, 2020 -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and commercialising cannabinoid.